Fidelity Advisor® Stk Selec Lg Cp Val A (FLUAX)
23.39
-0.08 (-0.34%)
USD |
May 19 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.06% | 510.22M | 0.84% | 76.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -25.21M | -1.93% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term growth of capital. The fund normally invests at least 80% of assets in stocks of companies with large market capitalizations (which, for purposes of this fund, are those companies with market capitalizations similar to companies in the Russell 1000® Index or the S&P 500® Index). It invests in securities of companies that the adviser believes are undervalued in the marketplace in relation to factors such as assets, sales, earnings, growth potential, or cash flow, or in relation to securities of other companies in the same industry. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FSLVX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| John Mirshekari | 11.15 yrs |
| Laurie Mundt | 11.15 yrs |
| Matthew Friedman | 11.15 yrs |
| John Sheehy | 5.84 yrs |
| Pierre Sorel | 3.84 yrs |
| Jordan Michaels | 0.41 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
54
-25.21M
-4.342B
Category Low
19.90B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 19, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 19, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| UnitedHealth Group Inc | 2.87% | 478.55 | 1.52% |
| Wells Fargo & Co | 2.59% | 42.00 | -0.26% |
| The Travelers Companies Inc | 2.42% | 169.30 | -2.88% |
| Exxon Mobil Corp | 2.34% | 91.14 | 0.54% |
| Bank of America Corp | 2.30% | 34.45 | -1.23% |
| Procter & Gamble Co | 2.06% | 141.70 | -2.30% |
| Johnson & Johnson | 2.03% | 173.94 | -0.89% |
| Thermo Fisher Scientific Inc | 2.01% | 550.74 | 1.58% |
|
Fidelity Revere Str Tr
|
1.92% | -- | -- |
| JPMorgan Chase & Co | 1.74% | 118.31 | -1.48% |
Basic Info
| Investment Strategy | |
| The investment seeks long-term growth of capital. The fund normally invests at least 80% of assets in stocks of companies with large market capitalizations (which, for purposes of this fund, are those companies with market capitalizations similar to companies in the Russell 1000® Index or the S&P 500® Index). It invests in securities of companies that the adviser believes are undervalued in the marketplace in relation to factors such as assets, sales, earnings, growth potential, or cash flow, or in relation to securities of other companies in the same industry. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FSLVX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| John Mirshekari | 11.15 yrs |
| Laurie Mundt | 11.15 yrs |
| Matthew Friedman | 11.15 yrs |
| John Sheehy | 5.84 yrs |
| Pierre Sorel | 3.84 yrs |
| Jordan Michaels | 0.41 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-19-22) | 0.84% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 16.24 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 2/13/2007 |
| Last Annual Report Date | 1/31/2022 |
| Last Prospectus Date | 4/1/2022 |
| Share Classes | |
| FLUEX | C |
| FLUIX | Inst |
| FLUTX | M |
| FSCZX | Inst |
| FSLVX | No Load |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |